Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of May 27
 -3.00 / -4.25%
Today’s Change
Today|||52-Week Range
Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans
May 27 / Zacks.com - Paid Partner Content
Alnylam Rises After Ionis Partner Decides Not To Start Phase 3 Study
May 26 / TheStreet.com - Paid Partner Content
Why Alnylam Pharmaceuticals, Inc. Competed Higher Today
May 26 / MotleyFool.com - Paid Partner Content
Better Buy: Alnylam Pharmaceuticals, Inc. vs. Ionis Pharmaceuticals Inc.
May 24 / MotleyFool.com - Paid Partner Content
Price Target Changed: Charter Communications (CHTR), Pure Storage (PSTG), Alnylam Pha...
May 26 / Investing Channel - Paid Partner Content
Drawing Biopharma Concepts With A Crayon
May 23 / MotleyFool.com - Paid Partner Content